SCRCQ — ScripsAmerica Share Price
Last trade - 00:00- $0.00m
- $2.45m
- $30.85m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 0 | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -13.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015E | 2016E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3.22 | 5.96 | 3.92 | 0.56 | 30.85 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +687.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.
Directors
- Brian Ettinger CHM (61)
- Adam Brosius PRE (50)
- Jeffrey Andrews CFO (62)
- Pelligrino Certa DRC (49)
- Joseph Camardo IND (61)
- Michael Imperiale IND (53)
- William Lewis IND (43)
- Andrius Pranskevicius IND (34)
- Last Annual
- December 31st, 2014
- Last Interim
- March 31st, 2015
- Incorporated
- May 12th, 2008
- Public Since
- May 30th, 2012
- No. of Employees
- 2
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 141,084,564
- Address
- 1094 Main Avenue, Suite A, CLIFTON, 07011
- Web
- http://scripsamerica.com/
- Phone
- +1 8009577622
- Auditors
- KMJ Corbin & Company LLP
Similar to SCRCQ
American Green
Pink Sheets on Nasdaq
Bit Brother
Pink Sheets on Nasdaq
Blue Gem Enterprise
Pink Sheets on Nasdaq
Blum Holdings
Pink Sheets on Nasdaq
Can B
Pink Sheets on Nasdaq
FAQ
As of Today at 23:07 UTC, shares in ScripsAmerica are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in ScripsAmerica last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the ScripsAmerica share price has underperformed the S&P500 Index by -16.06% over the past year.
There is no consensus recommendation for this security.
Find out moreScripsAmerica does not currently pay a dividend.
ScripsAmerica does not currently pay a dividend.
ScripsAmerica does not currently pay a dividend.
To buy shares in ScripsAmerica you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in ScripsAmerica had a market capitalisation of $0.00m.
Here are the trading details for ScripsAmerica:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SCRCQ
Based on an overall assessment of its quality, value and momentum ScripsAmerica is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ScripsAmerica. Over the past six months, its share price has underperformed the S&P500 Index by -5.16%.
As of the last closing price of $0.00, shares in ScripsAmerica were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ScripsAmerica PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ScripsAmerica's management team is headed by:
- Brian Ettinger - CHM
- Adam Brosius - PRE
- Jeffrey Andrews - CFO
- Pelligrino Certa - DRC
- Joseph Camardo - IND
- Michael Imperiale - IND
- William Lewis - IND
- Andrius Pranskevicius - IND